Effect group in full replicate Bioequivalence [Study Per­for­mance]

posted by Laura Carreiras – Portugal, 2022-05-11 13:11 (16 d 05:26 ago) – Posting: # 22969
Views: 226


In a in a bioequivalence study with a full replicate design conducted in more than one group, how shall the group participants be separated/divided?

For example,

Initially we have 3 groups but because of some constraints the washouts for a few participants had to be extended.

The participants will be added to the groups accordingly with the administration date of the first period (even if the other periods can have a different administration date) or the groups shall be formed accordingly with the date of administration of all the periods (for each group all the administration date of the 4 periods has to be the same)?

I hope I was clear.

Thank you for the help.

Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
 Admin contact
22,108 posts in 4,630 threads, 1,567 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Friday 18:37 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz